Visit Kalorama Information’s NEW store on scienceandmedicinegroup.com for our most recent 2025 market reports! 

Visit New Store

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

PharmaceuticalsX

Kalorama Information is a dependable resource for information on opportunity in the pharmaceutical market. The pharma industry has seen important developments in the last few years, bringing both challenges and new opportunities. The industry outlook for many manufacturers has changed due to outsourcing in drug discovery, growing generic competition and greater interest in biotechnology, among other developments. Our reports provide the sales data, revenue forecasts, and competitive analysis that one needs to understand the market.
Vaccines
Drug Delivery
Over-the-Counter
Drug Discovery
Cancer Treatment
Manufacturing & Packaging
Prescription Drugs

  • Worldwide Market for Pediatric Drugs, 2nd Edition, The
    $3,500.00 – $7,000.00
    Although, the next 15-20 years will shift a majority of the population into the elderly population group, children will continue to remain the bulk of the dependent population worldwide with 9 in every 10 people falling into a pediatric age range in the less developed regions of Africa, Asia and Latin America. Therefore, the treatment […]
    November 1, 2005
  • Worldwide Market for Cancer Diagnostics, The
    $3,500.00 – $7,000.00
    Cancer, with its high prevalence and mortality rate, continues to rank among the world’s deadliest and most costly diseases. According to the WHO, in 2003, about 25 million people live with cancer and nearly 11 million new cases are diagnosed each year. With advances in protein and cell chemistry, genetics and molecular biology researchers are […]
    October 1, 2005
  • The World Market for Neurotherapeutic Drugs
    $3,500.00 – $7,000.00
    Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This […]
    September 1, 2005
  • Complex Regional Pain Syndrome (CRPS) - A Market Briefing
    $795.00 – $1,990.00
    Neurological disease that impacts the sensory pathway can produce severe chronic pain, also known as neuropathic pain. This usually is unrelated to any peripheral tissue injury. This occurs with disorders of the central nervous system (CNS), such as stroke and multiple sclerosis, or with conditions associated with peripheral nerve damage, such as mechanical injury, diabetic […]
    August 1, 2005
  • The Market for Clinical Nutritional Products
    $2,500.00 – $5,000.00
    This market briefing concentrates on the U.S. market for medical nutritional support—in particular, the enteral and parenteral foods. The continuing development of equipment, medical foods, and feeding procedures that secure the nutrition of critically ill patents has greatly improved recovery and survival in select populations. Advances in the effectiveness and safety of nutritional procedures and […]
    August 1, 2005
  • The U.S Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications
    $3,000.00 – $6,000.00
    This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key […]
    July 1, 2005
  • The World Market for Anti-Infectives, Volume III - Antivirals
    $2,500.00 – $5,000.00
    This volume of Kalorama Information’s World Market for Anti-Infectives series focuses on three general product segments of antiviral treatment: Nucleoside Analogs Protease Inhibitors Other Misc. Antivirals The report covers both currently marketed and late stage development antiviral products in detail. For each segment, the report provides an An overview Description of products on the market […]
    June 1, 2005
  • Informatics in Drug Discovery: The Evolving Information Technology Marketplace
    $3,000.00 – $6,000.00
    Within the world of life science research, informatics plays a key role. A few years ago, this market space was occupied primarily by a few niche players, but over the past five years, established companies have expanded their offerings and hundreds of new software companies have surfaced. In the rapidly changing field of informatics, it […]
    May 1, 2005
  • The Worldwide Market for Prescription Cardiovascular Drugs
    $3,500.00 – $7,000.00
    The worldwide market for prescription cardiovascular drugs encompasses a wide variety of products that treat the many facets of cardiovascular disease. The field of cardiology is currently experiencing a busy and dynamic period. As a result, the range of therapeutic options available to physicians has expanded significantly in the past few years and the development […]
    May 1, 2005
  • The World Market for Anti-Infectives, Volume II - Antibacterials
    $2,500.00 – $5,000.00
    For the past 60 years, antibiotic drugs have changed bacterial infections from the life-threatening scourges they once were into eminently treatable conditions. However, the effectiveness of many antibiotics is waning dramatically, as more and more types of bacteria become resistant to traditional agents. As a result, pharmaceutical companies are taking a second look at the […]
    May 1, 2005